Asoprisnil: Difference between revisions
m Protected "Asoprisnil": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
Line 1: | Line 1: | ||
Line 37: | Line 37: | ||
<references/> | <references/> | ||
{{Sex hormones}} | {{Sex hormones}} | ||
[[Category:hormonal agents]] | [[Category:hormonal agents]] |
Latest revision as of 22:31, 8 August 2012
WikiDoc Resources for Asoprisnil |
Articles |
---|
Most recent articles on Asoprisnil |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Asoprisnil at Clinical Trials.gov Clinical Trials on Asoprisnil at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Asoprisnil
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Asoprisnil Discussion groups on Asoprisnil Patient Handouts on Asoprisnil Directions to Hospitals Treating Asoprisnil Risk calculators and risk factors for Asoprisnil
|
Healthcare Provider Resources |
Causes & Risk Factors for Asoprisnil |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Asoprisnil (J867) is a selective progesterone receptor modulator.[1]